Can adding nurses to primary care boost quality of life?

NCT ID NCT07784153

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time

Summary

This trial tests whether adding advanced practice nurses (APNs) to usual primary care improves quality of life for adults with stable chronic conditions. Participants are randomly assigned to receive care from a general practitioner alone or a coordinated GP-plus-APN pathway. The main goal is to measure changes in physical quality of life after 12 months, with secondary focus on hospitalizations and emergency visits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A coordinated care pathway involving advanced practice nurses (APNs) working alongside general practitioners (GPs)
What this could lead to
If effective, this approach could improve quality of life for people with chronic conditions and ease pressure on primary care systems.
What could go wrong
The trial is pragmatic and may face variability in how the pathway is implemented. Results may not generalize beyond the French primary care setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 880 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2028

An estimate. Start dates often move.

Expected to finish

Jul 2032

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 110 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years old or older patients, * patients with a stable chronic condition falling under the indications defined by the french decree of July 18, 2018, * patients under the care of a general practitioner (GP), * patients who have signed an informed consent form. Exclusion Criteria: * patients with cognitive impairments that compromise their ability to participate in the study, * patients who require exclusively medical care without the possibility of coordination, * patients already receiving care in a setting that includes a primary care nurse; * pregnant women; * patients with no legal capacity.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stable chronic condition are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.